STOCK TITAN

Enovis (ENOV) grants CAO 42,640 RSUs vesting over three years

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Enovis Corporation reported that Chief Administrative Officer Oliver Engert received an equity award in the form of restricted stock units on January 5, 2026. The award covers 42,640 shares of common stock at a stated price of $0.00 per share, reflecting a grant rather than an open‑market purchase.

According to the disclosure, these restricted stock units vest in three equal annual installments, beginning on the first anniversary of the grant date. Following this award, Engert is shown as beneficially owning 42,640 shares on a direct basis.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Engert Oliver

(Last) (First) (Middle)
2900 LAKE VISTA DRIVE
SUITE 200

(Street)
LEWISVILLE TX 75067

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Administrative Officer
3. Date of Earliest Transaction (Month/Day/Year)
01/05/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.001 01/05/2026 A 42,640(1) A $0.00 42,640 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.
/s/ Brian P. Hanigan, attorney-in-fact 01/16/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Enovis (ENOV) report for Oliver Engert?

The company reported that Chief Administrative Officer Oliver Engert received an award of 42,640 restricted stock units of Enovis common stock on January 5, 2026.

What type of securities were granted in this Enovis (ENOV) Form 4 filing?

The filing shows an award of restricted stock units tied to Enovis common stock, par value $0.001, covering 42,640 shares in total.

How do the Enovis (ENOV) restricted stock units granted to Oliver Engert vest?

The restricted stock units vest in three equal annual installments, starting on the first anniversary of the grant date of January 5, 2026.

What was the reported price for the Enovis (ENOV) stock units granted to Oliver Engert?

The transaction lists a price of $0.00 per share, indicating the award was granted as compensation rather than bought in the market.

How many Enovis (ENOV) shares does Oliver Engert beneficially own after this transaction?

After the reported award, the Form 4 shows that Oliver Engert beneficially owns 42,640 shares of Enovis common stock on a direct basis.

What is Oliver Engert’s role at Enovis (ENOV) according to this filing?

The filing identifies Oliver Engert as an officer of Enovis, serving as the company’s Chief Administrative Officer.
Enovis Corp

NYSE:ENOV

ENOV Rankings

ENOV Latest News

ENOV Latest SEC Filings

ENOV Stock Data

1.39B
56.28M
1.57%
121.34%
12.07%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WILMINGTON